Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
BeiGene, Ltd. (BGNE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/02/2023 |
4
| Lee Chan Henry (SVP, General Counsel) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 791 shares
@ $216.2567, valued at
$171.1k
|
|
| 07/06/2023 |
4
| Wang Julia Aijun (CFO) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 472 shares
@ $179.5495, valued at
$84.7k
|
|
| 06/15/2023 |
4
| HHLR ADVISORS, LTD. (10% Owner) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 611,000 shares
@ $211.4522, valued at
$129.2M
Sold 313,400 shares
@ $128.4335, valued at
$40.3M
Sold 273,728 shares
@ $207.7171, valued at
$56.9M
|
|
| 06/12/2023 |
4
| HHLR ADVISORS, LTD. (10% Owner) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 1,163,825 shares
@ $218.1443, valued at
$253.9M
Sold 213,700 shares
@ $130.3523, valued at
$27.9M
Sold 328,952 shares
@ $217.0183, valued at
$71.4M
Sold 281,400 shares
@ $130.8322, valued at
$36.8M
Sold 968,812 shares
@ $213.9125, valued at
$207.2M
|
|
| 06/09/2023 |
4
| Wang Lai (Global Head of R&D) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 74 shares
@ $223.2333, valued at
$16.5k
Sold 161 shares
@ $224.0403, valued at
$36.1k
Sold 111 shares
@ $225.2721, valued at
$25k
Sold 116 shares
@ $226.1511, valued at
$26.2k
|
|
| 06/09/2023 |
4
| Wu Xiaobin (President, COO & GM China) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 531 shares
@ $223.2333, valued at
$118.5k
Sold 1,147 shares
@ $224.0403, valued at
$257k
Sold 789 shares
@ $225.2721, valued at
$177.7k
Sold 824 shares
@ $226.1511, valued at
$186.3k
|
|
| 05/10/2023 |
4
| Wu Xiaobin (President, COO & GM China) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 7,000 shares
@ $253.7196, valued at
$1.8M
|
|
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2023 |
4
| Wang Xiaodong (Director) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Exercised 67,635 shares
@ $0.13, valued at
$8.8k
Sold 3,433 shares
@ $222.9985, valued at
$765.6k
Sold 7,458 shares
@ $224.0088, valued at
$1.7M
Sold 12,534 shares
@ $224.9239, valued at
$2.8M
Sold 400 shares
@ $225.3475, valued at
$90.1k
Sold 200 shares
@ $226.6109, valued at
$45.3k
Sold 14,077 shares
@ $225.9541, valued at
$3.2M
Sold 17,170 shares
@ $227.1205, valued at
$3.9M
Sold 12,363 shares
@ $227.7809, valued at
$2.8M
Exercised 879,255 options to buy
@ $0.01, valued at
$8.8k
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2023 |
4
| OYLER JOHN (CEO) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 879 shares
@ $246.9951, valued at
$217.1k
Sold 2,442 shares
@ $247.7357, valued at
$605k
Sold 1,336 shares
@ $248.7626, valued at
$332.3k
Sold 1,948 shares
@ $249.8361, valued at
$486.7k
Sold 192 shares
@ $250.2613, valued at
$48.1k
Sold 879 shares
@ $246.9958, valued at
$217.1k
Sold 2,442 shares
@ $247.7358, valued at
$605k
Sold 1,336 shares
@ $248.7628, valued at
$332.3k
Sold 1,948 shares
@ $249.8363, valued at
$486.7k
Sold 192 shares
@ $250.2613, valued at
$48.1k
Sold 879 shares
@ $246.9661, valued at
$217.1k
|
|
| 01/11/2023 |
4
| Wang Xiaodong (Director) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 900 shares
@ $250, valued at
$225k
Sold 1,600 shares
@ $250.0948, valued at
$400.2k
Sold 200 shares
@ $250.3872, valued at
$50.1k
Sold 1,250 shares
@ $252.2246, valued at
$315.3k
Sold 950 shares
@ $253.5674, valued at
$240.9k
Sold 100 shares
@ $254, valued at
$25.4k
|
|
| 12/29/2022 |
4
| OYLER JOHN (CEO) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 1,120 shares
@ $224.2934, valued at
$251.2k
Sold 1,120 shares
@ $224.2936, valued at
$251.2k
Sold 1,119 shares
@ $224.2935, valued at
$251k
Sold 367 shares
@ $224.7252, valued at
$82.5k
Sold 366 shares
@ $224.7252, valued at
$82.2k
Sold 367 shares
@ $224.7252, valued at
$82.5k
Sold 1,625 shares
@ $224.423, valued at
$364.7k
Sold 91 shares
@ $225.1308, valued at
$20.5k
Sold 1,625 shares
@ $224.4227, valued at
$364.7k
Sold 92 shares
@ $225.1296, valued at
$20.7k
Sold 1,625 shares
@ $224.4228, valued at
$364.7k
|
|
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2022 |
4
| OYLER JOHN (CEO) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 1,400 shares
@ $203.6383, valued at
$285.1k
Sold 2,333 shares
@ $204.601, valued at
$477.3k
Sold 4,081 shares
@ $205.6736, valued at
$839.4k
Sold 4,456 shares
@ $206.5701, valued at
$920.5k
Sold 7,643 shares
@ $207.6622, valued at
$1.6M
Sold 4,487 shares
@ $208.5482, valued at
$935.8k
Sold 600 shares
@ $209.8817, valued at
$125.9k
Sold 700 shares
@ $204.2403, valued at
$143k
Sold 884 shares
@ $205.5234, valued at
$181.7k
Sold 1,009 shares
@ $206.5129, valued at
$208.4k
Sold 835 shares
@ $207.622, valued at
$173.4k
|
|
| 09/22/2022 |
4
| OYLER JOHN (CEO) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 9,749 shares
@ $153.3184, valued at
$1.5M
Sold 5,411 shares
@ $153.8057, valued at
$832.2k
Sold 100 shares
@ $154.77, valued at
$15.5k
Sold 9,748 shares
@ $153.3184, valued at
$1.5M
Sold 5,412 shares
@ $153.8057, valued at
$832.4k
Sold 100 shares
@ $154.77, valued at
$15.5k
Sold 2,000 shares
@ $148.251, valued at
$296.5k
Sold 2,639 shares
@ $149.2122, valued at
$393.8k
Sold 2,435 shares
@ $150.3532, valued at
$366.1k
Sold 1,716 shares
@ $151.163, valued at
$259.4k
Sold 500 shares
@ $152.349, valued at
$76.2k
|
|
| 09/08/2022 |
4
| Wang Xiaodong (Director) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Gifted 33,410 shares
@ $0 |
|
| 08/24/2022 |
4
| Yi Qingqing (Director) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Disposed of 7,800 shares
@ $0 |
|
| 08/24/2022 |
4
| HHLR ADVISORS, LTD. (10% Owner) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Acquired 7,800 shares
@ $0 |
|
| 08/09/2022 |
4
| Wang Xiaodong (Director) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 300 shares
@ $186.6922, valued at
$56k
Sold 200 shares
@ $188.87, valued at
$37.8k
Sold 100 shares
@ $190.19, valued at
$19k
Sold 100 shares
@ $191.6, valued at
$19.2k
Sold 2,100 shares
@ $193.704, valued at
$406.8k
Sold 600 shares
@ $194.3811, valued at
$116.6k
Sold 1,000 shares
@ $195.6318, valued at
$195.6k
Sold 400 shares
@ $196.575, valued at
$78.6k
Sold 100 shares
@ $197.65, valued at
$19.8k
Sold 100 shares
@ $198.77, valued at
$19.9k
Sold 300 shares
@ $186.5607, valued at
$56k
|
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4
| Wang Lai (Global Head of R&D) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 458 shares
@ $177.3247, valued at
$81.2k
|
|
| 06/24/2022 |
4
| OYLER JOHN (CEO) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Granted 334,009 shares
@ $0
Granted 1,887,678 options to buy
@ $0 |
|
| 06/24/2022 |
4
| Wang Lai (Global Head of R&D) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Granted 125,255 shares
@ $0
Granted 707,876 options to buy
@ $0 |
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Dugan Margaret (Director) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Granted 16,692 shares
@ $0
Granted 34,645 options to buy
@ $0 |
|
| 06/24/2022 |
4
| Wang Xiaodong (Director) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Granted 83,499 shares
@ $0
Granted 471,913 options to buy
@ $0 |
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Glazer Donald W. (Director) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Granted 16,692 shares
@ $0
Granted 34,645 options to buy
@ $0 |
|
| 06/24/2022 |
4
| Riva Alessandro (Director) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Granted 16,692 shares
@ $0
Granted 34,645 options to buy
@ $0 |
|
| 06/24/2022 |
4
| Sanders Corazon (Corsee) D. (Director) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Granted 16,692 shares
@ $0
Granted 34,645 options to buy
@ $0 |
|
|
|
|